Todays Biggest Pre-Market Stock Movers 10 Top Gainers and Losers on Tuesday
| TCBPDelisted Stock | USD 0.50 0.00 0.00% |
Slightly above 62% of TC BioPharm's investor base is looking to short. The analysis of overall sentiment of trading TC BioPharm Holdings pink sheet suggests that many investors are alarmed at this time. TC BioPharm's investing sentiment overview a quick insight into current market opportunities from investing in TC BioPharm Holdings. Many technical investors use TC BioPharm Holdings stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
TCBP |
Were starting off the day with a look at the biggest pre-market stock movers traders will want to keep an eye on Tuesday
Read at investorplace.com
 |
TC BioPharm Fundamental Analysis
We analyze TC BioPharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TC BioPharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TC BioPharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
TC BioPharm is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
TC BioPharm Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with TC BioPharm pink sheet to make a market-neutral strategy. Peer analysis of TC BioPharm could also be used in its relative valuation, which is a method of valuing TC BioPharm by comparing valuation metrics with similar companies.
Peers
TC BioPharm Related Equities
| ZVSA | ZyVersa Therapeutics | 9.44 | ||||
| UNCY | Unicycive Therapeutics | 6.69 | ||||
| QNRX | Quoin Pharmaceuticals | 5.62 | ||||
| SONN | Sonnet Biotherapeutics | 4.42 | ||||
| VRAX | Virax Biolabs | 2.94 | ||||
| PALI | Palisade Bio | 2.35 | ||||
| IMMX | Immix Biopharma | 1.01 | ||||
| BDRX | Biodexa Pharmaceticals | 0.87 | ||||
| PHIO | Phio Pharmaceuticals | 1.14 | ||||
| ICU | LMF Acquisition | 1.59 | ||||
| ZURA | Zura Bio | 1.92 | ||||
| RNAZ | Transcode Therapeutics | 2.44 | ||||
| ALLR | Allarity Therapeutics | 4.95 | ||||
| REVB | Revelation Biosciences | 5.35 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in TCBP Pink Sheet
If you are still planning to invest in TC BioPharm Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TC BioPharm's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |